InMode Ltd (INMD)
29.85
-1.04 (-3.37%)
USD |
NASDAQ |
Mar 17, 16:00
29.53
-0.32 (-1.07%)
After-Hours: 04:57
InMode Revenue (TTM): 454.27M for Dec. 31, 2022
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2022 | 454.27M |
| September 30, 2022 | 431.24M |
| June 30, 2022 | 404.18M |
| March 31, 2022 | 377.96M |
| December 31, 2021 | 357.56M |
| September 30, 2021 | 322.21M |
| June 30, 2021 | 287.75M |
| March 31, 2021 | 231.19M |
| December 31, 2020 | 206.11M |
| Date | Value |
|---|---|
| September 30, 2020 | 177.92M |
| June 30, 2020 | 158.22M |
| March 31, 2020 | 166.25M |
| December 31, 2019 | 156.36M |
| September 30, 2019 | 138.14M |
| June 30, 2019 | 123.55M |
| March 31, 2019 | 109.80M |
| December 31, 2018 | 100.16M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
100.16M
Minimum
Dec 2018
454.27M
Maximum
Dec 2022
247.23M
Average
206.11M
Median
Dec 2020
Revenue (TTM) Benchmarks
| Can Fite Biofarma Ltd | 0.817M |
| BiomX Inc | -- |
| Compugen Ltd | -- |
| Pluri Inc | -- |
| BioLine Rx Ltd | -- |